BI YEARLY TENDER RATE CONTRACT FOR THE SUPPLY OF VACCINE TO MUNICIPAL HOSPITALS MATERNITY HOMES HEALTH CENTRES AND DISPENSARIES FOR THE YEAR 2025 TO 2026 AND 2026 TO 2027

Inj. Anti Rabies Vaccine For Human Use with1 ml Diluent & five Disposable 1 ml (Insulin) Syringe with fixed (self mounted) (28 G or more) needle approved by DCGI for Intra Dermal Use.(The Vaccine Package leaflet should include a statement indicating that the potency as well as immunogenicity & safety allow safe use of Vaccine by both the IM & ID routes for post - exposure & pre exposure prophylaxis) (1 x 1 vial of Lyophilized Powder with 1 ml Diluent)

Inj. Anti Rabies Vaccine For Human Use with1 ml Diluent & five Disposable 0.5 ml (Insulin) Syringe with fixed (self mounted) (28 G or more) needle approved by DCGI for Intra Dermal Use.(The Vaccine Package leaflet should include a statement indicating that the potency as well as immunogenicity & safety allow safe use of Vaccine by both the IM & ID routes for post - exposure & pre exposure prophylaxis) (1 x 1 vial of Lyophilized Powder with 0.5 ml Diluent)

Inj. Tetanus Toxoid 5 ml Vial ( 1 x 5 ml.)

Inj. Tetanus Toxoid 0.5 ml Amp. ( 1 x 0.5 ml.)

Anti Scorpio Venoum (Lyphilised Monovalent Enzume with sterile water 10 ml)

Human Rabies Immunoglobulin( 300 IU) Prefilled syringe with 2 ml

Recombinant Monoclonal Antibodies (Rmab) 100 IU/2.5ml against rabies.